Literature DB >> 1452713

Novel coagglutination method for serotyping group B streptococci.

S Håkansson1, L G Burman, J Henrichsen, S E Holm.   

Abstract

A group G streptococcal strain was coated with antibody against six different serotypes (Ia, Ib, II, III, IV, and V) of group B streptococci. The coagglutination patterns of 114 strains of group B streptococci were compared with the serotypes determined after immunoprecipitation. The specificity of the method was 100% and the sensitivity 97%. It was used for the typing of 89 invasive and 101 colonizing isolates. The new method is swift, specific, and highly sensitive. It consumes only minute amounts of antibody.

Mesh：

Year:  1992        PMID： 1452713      PMCID： PMC270646          DOI： 10.1128/jcm.30.12.3268-3269.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  4 in total

Review 1.  Group B streptococci in the human population.

Authors:  J Jelínkoá
Journal:  Curr Top Microbiol Immunol       Date:  1977       Impact factor: 4.291

2.  Biosynthetic capacity for type-specific antigen synthesis determines the virulence of serotype III strains of group B streptococci.

Authors:  M K Yeung; S J Mattingly
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

3.  Density profile of group B streptococci, type III, and its possible relation to enhanced virulence.

Authors:  S Håkansson; S E Holm; M Wagner
Journal:  J Clin Microbiol       Date:  1987-04       Impact factor: 5.948

4.  Purification and some properties of streptococcal protein G, a novel IgG-binding reagent.

Authors:  L Björck; G Kronvall
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422
  4 in total
  8 in total

1.  Identification of Group B Streptococcus Capsule Type by Use of a Dual Phenotypic/Genotypic Assay.

Authors:  Areej Alhhazmi; Armaan Pandey; Gregory J Tyrrell
Journal:  J Clin Microbiol       Date:  2017-06-14       Impact factor: 5.948

2.  DNA polymorphism and molecular subtyping of the capsular gene cluster of group B streptococcus.

Authors:  Shannon D Manning; David W Lacher; H Dele Davies; Betsy Foxman; Thomas S Whittam
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

3.  Genotyping of the capsule gene cluster (cps) in nontypeable group B streptococci reveals two major cps allelic variants of serotypes III and VII.

Authors:  M Sellin; C Olofsson; S Håkansson; M Norgren
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

4.  Use of a serotype-specific DNA microarray for identification of group B Streptococcus (Streptococcus agalactiae).

Authors:  Linyan Wen; Quan Wang; Yayue Li; Fanrong Kong; Gwendolyn L Gilbert; Boyang Cao; Lei Wang; Lu Feng
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

5.  International external quality assurance for laboratory identification and typing of Streptococcus agalactiae (Group B streptococci).

Authors:  Baharak Afshar; Karen Broughton; Roberta Creti; Antoaneta Decheva; Markus Hufnagel; Paula Kriz; Lotte Lambertsen; Marguerite Lovgren; Pierrette Melin; Graziella Orefici; Claire Poyart; Andreas Radtke; Javier Rodriguez-Granger; Uffe B Skov Sørensen; John Telford; Lea Valinsky; Levantia Zachariadou; Androulla Efstratiou
Journal:  J Clin Microbiol       Date:  2011-02-16       Impact factor: 5.948

6.  Serotype identification of group B streptococci by PCR and sequencing.

Authors:  Fanrong Kong; Sonia Gowan; Diana Martin; Gregory James; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

7.  Comparison of DNA dot blot hybridization and lancefield capillary precipitin methods for group B streptococcal capsular typing.

Authors:  Stephanie M Borchardt; Betsy Foxman; Donald O Chaffin; Craig E Rubens; Patricia A Tallman; Shannon D Manning; Carol J Baker; Carl F Marrs
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

Review 8.  Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries.

Authors:  Miwako Kobayashi; Johan Vekemans; Carol J Baker; Adam J Ratner; Kirsty Le Doare; Stephanie J Schrag
Journal:  F1000Res       Date:  2016-09-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.